Germany says production capacity, not patents, key to upping vaccine output
The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany’s health minister said Friday, reiterating Berlin’s opposition to a U.S. proposal to waive patent protection.
Read More
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case